Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition. (Q40469450)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition. |
scientific article |
Statements
Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition (English)
Henry S Friedman
1 reference
Darell D Bigner
David A Reardon
1 reference
Roger E McLendon
Jeremy N Rich
Stephen T Keir
Carol J Wikstrand
Ranjit K Goudar
Qing Shi
Elizabeth D Reese
Charles A Conrad
Peter Traxler
Heidi A Lane
Webster K Cavenee
Xiao-Fan Wang
David A Reardon
Henry S Friedman
1 January 2005